These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 9555723)

  • 1. Therapeutic repair of mutated nucleic acid sequences.
    Woolf TM
    Nat Biotechnol; 1998 Apr; 16(4):341-4. PubMed ID: 9555723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted gene repair in mammalian cells using chimeric RNA/DNA oligonucleotides and modified single-stranded vectors.
    Parekh-Olmedo H; Czymmek K; Kmiec EB
    Sci STKE; 2001 Mar; 2001(73):pl1. PubMed ID: 11752645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trans-splicing ribozymes for targeted gene delivery.
    Köhler U; Ayre BG; Goodman HM; Haseloff J
    J Mol Biol; 1999 Feb; 285(5):1935-50. PubMed ID: 9925776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization and application of the group I ribozyme trans-splicing reaction.
    Einvik C; Fiskaa T; Lundblad EW; Johansen S
    Methods Mol Biol; 2004; 252():359-71. PubMed ID: 15017063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays.
    Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G
    J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Repair of the splicing defect of thalassemic allele beta IVS-2-654 C-->T in cultured human erythroid cells by antisense RNA].
    Gu X; Gong L; Zhang W
    Zhonghua Yi Xue Za Zhi; 1997 Nov; 77(11):815-8. PubMed ID: 9772473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The application of ribozymes to HIV infection.
    Rossi JJ
    Curr Opin Mol Ther; 1999 Jun; 1(3):316-22. PubMed ID: 11713796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy.
    Gurvich OL; Tuohy TM; Howard MT; Finkel RS; Medne L; Anderson CB; Weiss RB; Wilton SD; Flanigan KM
    Ann Neurol; 2008 Jan; 63(1):81-9. PubMed ID: 18059005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing RNA repair efficiency by combining trans-splicing ribozymes that recognize different accessible sites on a target RNA.
    Lan N; Rooney BL; Lee SW; Howrey RP; Smith CA; Sullenger BA
    Mol Ther; 2000 Sep; 2(3):245-55. PubMed ID: 10985955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothesis: transcript-templated repair of DNA double-strand breaks.
    Trott DA; Porter AC
    Bioessays; 2006 Jan; 28(1):78-83. PubMed ID: 16369940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA reprogramming of alpha-mannosidase mRNA sequences in vitro by myxomycete group IC1 and IE ribozymes.
    Fiskaa T; Lundblad EW; Henriksen JR; Johansen SD; Einvik C
    FEBS J; 2006 Jun; 273(12):2789-800. PubMed ID: 16817905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spliceosome-mediated RNA trans-splicing.
    Yang Y; Walsh CE
    Mol Ther; 2005 Dec; 12(6):1006-12. PubMed ID: 16226059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation in Brca2 stimulates error-prone homology-directed repair of DNA double-strand breaks occurring between repeated sequences.
    Tutt A; Bertwistle D; Valentine J; Gabriel A; Swift S; Ross G; Griffin C; Thacker J; Ashworth A
    EMBO J; 2001 Sep; 20(17):4704-16. PubMed ID: 11532935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy. Repair kits for faulty genes.
    Ferber D
    Science; 2001 Nov; 294(5547):1639. PubMed ID: 11721030
    [No Abstract]   [Full Text] [Related]  

  • 15. Suppression of gene expression by targeted disruption of messenger RNA: available options and current strategies.
    Jen KY; Gewirtz AM
    Stem Cells; 2000; 18(5):307-19. PubMed ID: 11007915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo targeted repair of a point mutation in the canine dystrophin gene by a chimeric RNA/DNA oligonucleotide.
    Bartlett RJ; Stockinger S; Denis MM; Bartlett WT; Inverardi L; Le TT; thi Man N; Morris GE; Bogan DJ; Metcalf-Bogan J; Kornegay JN
    Nat Biotechnol; 2000 Jun; 18(6):615-22. PubMed ID: 10835598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleic acids in therapy.
    Datar RH
    Natl Med J India; 2001; 14(5):290-6. PubMed ID: 11767224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoring DNA repair capacity of cells from three distinct diseases by XPD gene-recombinant adenovirus.
    Armelini MG; Muotri AR; Marchetto MC; de Lima-Bessa KM; Sarasin A; Menck CF
    Cancer Gene Ther; 2005 Apr; 12(4):389-96. PubMed ID: 15650764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA replication and transcription direct a DNA strand bias in the process of targeted gene repair in mammalian cells.
    Brachman EE; Kmiec EB
    J Cell Sci; 2004 Aug; 117(Pt 17):3867-74. PubMed ID: 15265980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered ribozymes as molecular tools for site-specific alteration of RNA sequence.
    Müller S
    Chembiochem; 2003 Oct; 4(10):991-7. PubMed ID: 14523916
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.